Breaking News! We are very proud at InSphero to announce the closing of an eight-figure growth financing round to roll out our cryo-preserved 3D microtissue portfolio.
In this round, we are very happy to have ZEISS Ventures as a strategic investor on board. In close collaboration with ZEISS Microscopy, the venture group at ZEISS led the round.
The widespread use of 3D microtissues following the ratification of the FDA Modernization Act requires efficient, automation-compatible, and scalable 3D models quickly. Our ground-breaking, cryopreserved ARCTis 3D Microtissue portfolio offers a storable, always ready-to-use solution to efficient and insightful compound testing. We are on the way to becoming the biggest 3D microtissue biobank in the world and we are glad to have the support from an experienced investor of the caliber of ZEISS Ventures for this journey.
Welcome, ZEISS Ventures!
#innovation #drugdevelopment #3dcellculture #organoids
https://lnkd.in/eampjjga
InSphero announces the closing of an eight-figure growth financing round to roll out their cryo-preserved 3D microtissue portfolio
Apr 14, 2023
ZEISS Ventures invests in life science start-up InSphero
Posted by InSphero